Matt O’Brien

With Zimmer Biomet Holdings Inc (NYSE: ZBH) reporting a third-quarter miss and slashing its guidance, Piper Jaffray downgraded shares of the Zimmer Biomet Holdings Inc (NYSE: ZBH).  Analyst Matt O'Brien dowgraded Zimmer Biomet from Overweight to Neutral and lowered his price target from...